Literature DB >> 8508513

Detection of dopamine--DNA adducts: potential role in Parkinson's disease.

G Lévay1, W J Bodell.   

Abstract

Oxidation of catecholamines may lead to the formation of o-semiquinones and o-quinones in catecholaminergic brain tissues, and these reactive molecules may form DNA or protein adducts. In this study, cultured cells were treated with dopamine (DA) for 24 h and 32P-postlabelling was used to detect DA-DNA adducts. In HL-60 cells, 250 microM DA induced 8.5 DNA adducts/10(8) nucleotides; adduct formation was dose-dependent up to 500 microM DA. Addition of H2O2 increased the relative adduct levels 7- to 13-fold, but no adducts were detected when DA and ascorbic acid were added simultaneously. In human glioblastoma cell lines U87, U251, SF-763 and SF-767, 1000 microM DA produced 0.98-2.31 adducts/10(8) nucleotides. These results suggest that the formation of DNA adducts by DA may contribute to the development of certain neurodegenerative diseases such as Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508513     DOI: 10.1093/carcin/14.6.1241

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.

Authors:  Chelsea T Tiernan; Ethan A Edwin; Hae-Young Hawong; Mónica Ríos-Cabanillas; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2015-01-19       Impact factor: 4.849

Review 2.  The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair.

Authors:  P J Brooks
Journal:  DNA Repair (Amst)       Date:  2008-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.